ACE2-independent sarbecovirus cell entry is supported by TMPRSS2-related enzymes and reduces sensitivity to antibody-mediated neutralization

Author Reply to Peer Reviews of ACE2-independent sarbecovirus cell entry can be supported by TMPRSS2-related enzymes and can reduce sensitivity to antibody-mediated neutralization

Author Reply to Peer Reviews of Macrophage- and CD4+ T cell-derived SIV differ in glycosylation, infectivity and neutralization sensitivity

BNT162b2 boosted immune responses six months after heterologous or homologous ChAdOx1nCoV-19/BNT162b2 vaccination against COVID-19

Development of immortalized Callithrix jacchus kidney cell lines supporting infection with a panel of viruses

Discovery of Polyphenolic Natural Products as SARS-CoV-2 Mpro Inhibitors for COVID-19

Evidence for influenza B virus hemagglutinin adaptation to the human host: high cleavability, acid-stability and preference for cool temperature

Filamentous Fungus-Produced Human Monoclonal Antibody Provides SARS-CoV-2 Protection in Hamster and Non-Human Primate Models

Functional comparison of MERS-coronavirus lineages reveals increased zoonotic potential of the recombinant lineage 5

Humoral and cellular immune response against SARS-CoV-2 variants following heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination.

Impact of JN.1 booster vaccination on neutralisation of SARS-CoV-2 variants KP.3.1.1 and XEC

Interferon induction and not replication interference mainly determines anti-influenza virus activity of defective interfering particles

LRRC15 mediates an accessory interaction with the SARS-CoV-2 spike protein

MCMV based vaccine vectors expressing full-length viral proteins provide long-term humoral immune protection upon a single-shot vaccination

Macrophage- and CD4 + T cell-derived SIV differ in glycosylation, infectivity and neutralization sensitivity

Probing Multivalent Lectin-Carbohydrate Binding via Multifunctional Glycan-Gold Nanoparticles: Implications for Blocking Virus Infection

Proteolytic processing of the Marburg virus glycoprotein depends on Sec61β and is required for cell entry

Q1020R in the spike proteins of MERS-CoV from Arabian camels and recent human cases confers resistance against soluble human DPP4

SARS-CoV-2 mutations acquired in mink reduce antibody-mediated neutralization

SARS-CoV-2 variants B.1.351 and B.1.1.248: Escape from therapeutic antibodies and antibodies induced by infection and vaccination

The Omicron variant is highly resistant against antibody-mediated neutralization – implications for control of the COVID-19 pandemic

The RNA demethylase FTO controls m6A marking on SARS-CoV-2 and classifies COVID-19 severity in patients

The SARS-CoV-2 and other human coronavirus spike proteins are fine-tuned towards temperature and proteases of the human airways

Virological traits of the SARS-CoV-2 BA.2.87.1 lineage